Scientists Take On 'Year Of The Glove'

For scientists and health care professionals working with blood and tissue products, 1988 may well go down in history as the “Year of the Glove,” as the demand for rubber gloves soars. “We’ve seen a doubling of demand since the last quarter of 1987,” says Les Jacobson, of Baxter International Inc., a large medical glove manufacturer based in Chicago, Ill. “Glove manufacturers are switching their product mix— robbing Peter to pay Paul—to ease th

Written byAubin Tyler
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For scientists and health care professionals working with blood and tissue products, 1988 may well go down in history as the “Year of the Glove,” as the demand for rubber gloves soars.

“We’ve seen a doubling of demand since the last quarter of 1987,” says Les Jacobson, of Baxter International Inc., a large medical glove manufacturer based in Chicago, Ill. “Glove manufacturers are switching their product mix— robbing Peter to pay Paul—to ease the shortage.”

Ansell Inc., another major glove maker, based in Dothan, Ala., increased its glove production to 2.5 billion this year—twice last year’s output. Many glove makers have added extra shifts, or slowed down on other product lines in order to increase glove production. And in rubber-producing regions in the Far East, a few startup companies are now cashing in on U.S. demand.

The rush to glove-up started last year after the Centers for Disease Control published ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies